ISB News

Brain Health & Research Institute Enters Scientific Partnership with ISB, Aims to Provide Patients with Hope, Proven Results

Brain health expert Dr. Mary Kay Ross on Tuesday announced the creation of the Brain Health & Research Institute (BHRI) in Seattle. The new institute is dedicated to the evaluation, prevention, and treatment of neurodegenerative diseases, including Alzheimer’s Disease and dementia.

Dr. Mary Kay Ross

Brain health expert Dr. Mary Kay Ross announced the new Brain Health & Research Institute, which opens its doors in Seattle in September 2019.

BHRI has entered into a scientific collaboration with ISB. Through that partnership, BHRI will blend the practical application of medical therapies and treatment protocols with the advanced scientific analysis now available through personalized medicine and computational biology.

“This is a unique opportunity to bring the most advanced concepts in personalized medicine, with scientific rigor, to crippling diseases such as Alzheimer’s Disease,” said ISB President Dr. Jim Heath.

BHRI will open its doors in September.

“Our work must remain on the leading edge of biology, but must also be put to use for the benefit of millions of people suffering the scourge of brain disease,” said Dr. Lee Hood, ISB co-founder and senior vice president and chief science officer of Providence St. Joseph Health. “With her years of successful functional medicine practice and her deep experience with the complex and layered nature of Alzheimer’s I couldn’t be any prouder of our scientific partnership with Dr. Ross and her team.”

All patient-related questions should be directed to Brain Health & Research Institute. Please contact them here

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.